Wang Xiaolin Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$70,132.88

Insider Activity of Wang Xiaolin

According to the SEC Form 4 filings, Wang Xiaolin, being in a position of

  1. See Remarks at Revolution Medicines, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2010 shares for $199,956,
    over all time since 2021-06-17, has bought 0 shares, and sold 5087 shares for $270,088.

Biography of Wang Xiaolin

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $199,9561100

Comparison of Insiders on Amount of Buys and Sells

2026-03-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
2,010
0.001%
$99.48$199,956+85.54%
2023-03-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
714
0.0008%
$21.78$15,551+22.45%
2022-12-19SaleRevolution Medicines, Inc.
RVMD
See Remarks
708
0.0009%
$22.94$16,241+15.63%
2022-06-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
665
0.0009%
$17.75$11,803+27.65%
2022-03-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
240
0.0003%
$18.61$4,467+15.02%
2021-12-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
257
0.0003%
$24.41$6,273-18.28%
2021-09-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
250
0.0003%
$30.02$7,505-25.68%
2021-06-17SaleRevolution Medicines, Inc.
RVMD
See Remarks
243
0.0003%
$34.12$8,291-24%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.